Inhaler Corporations Must Be Held Accountable for Ripping Off Vermonters and the American People
That is why this week, as Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), I launched an investigation into the four biggest manufacturers of inhalers sold in the U.S. — AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline (GSK), and Teva. They must be held accountable for charging the American people inhaler prices that are often 10 to 20 times higher than what they charge in other countries.